Download PDF
1 / Pages

Other users also viewed these articles

Gut-related molecules as potential biomarkers in patients with decompensated cirrhosis Camila Marques de Alcântara Barreto; Eliane Almeida do Valle; Jessica Pronestino de Lima Moreira; Katia Farias e Silva; Siane Lopes Bittencourt Rosas; Patrícia Teixeira Santana; Ana Maria Pittella; Gustavo Pereira; Flavia Ferreira Fernandes; Renata de Mello Perez; Heitor Siffert Pereira de Souza;
10.1016/j.aohep.2024.101567
Challenges in the management of alcohol-associated liver disease in Latin America Francisco Idalsoaga; Luis Antonio Diaz; Gustavo Ayares; Marco Arrese; Juan Pablo Arab;
10.1016/j.aohep.2024.101748
OP-1 LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: INTERIM 2-YEAR RESULTS FROM THE ASSURE STUDY Palak J. Trivedi; Cynthia Levy; Kris V. Kowdley; Stuart C. Gordon; Christopher L. Bowlus; Maria Carlota Londoño Hurtado; Gideon M. Hirschfield; Aliya F. Gulamhusien; Eric J. Lawitz; Alejandra Villamil; Alma Ladron de Guevara Cetina; Marlyn J. Mayo; Ziad H. Younes; Oren Shibolet; Kidist K. Yimam; Daniel S. Pratt; Jeong Heo; Ulrike Morgera; Pietro Andreone; Andreas E. Kremer; Christophe Corpechot; Aparna Goel; Adam Peyton; Hany Elbeshbeshy; Daria B. Crittenden; Carrie Heusner; Sarah Proehl; Shuqiong Zhou; Charles A. McWherter;
Ann Hepatol. 2024;29 Supl 3: